Lupin receives FDA approval for generic Safyral Tablets

02 January 2018 | News

Tydemy is indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception

Pharma Major Lupin recently announced that it has received final approval for its Tydemy (Drospirenone, Ethinyl Estradiol, and Levomefolate Calcium Tablets, 3 mg/0.03 mg/0.451 mg and Levomefolate Calcium Tablets, 0.451 mg) from the United States Food and Drug Administration (FDA) to market a generic version of Safyral Tablets of Bayer HealthCare Pharmaceuticals Inc.